Vanda Pharmaceuticals Inc.

VNDA | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.16

+$0.03 (+0.58%)

At close: Sep 21, 2026, 4:00 PM ET

$5.15

-$0.01 (-0.19%)

Pre-market: Sep 22, 2026, 7:33 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.58%

(1D)

Rating

Updated: Aug 20, 2026

30.5

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $310M

1D Range

5.05 5.17

52W Range

4.27 9.94

Valuation (TTM)

PE -1.11

PB 1.41

EV/EBITDA -0.84

Valuation (NTM)

Forward PE N/A

Forward PEG 0.02

Price Target $21

Cash Flow

FCF Yield -62.4%

SBC Adj. FCF Yield -66.2%

SBC Impact -6.0%

Margins

Gross Margin 92.8%

Operating Margin -86.1%

FCF Margin -89.7%

Growth (CAGR)

Revenue 3Y | 5Y -3.3% | -3.6%

Dil EPS 3Y | 5Y -111.7% | -100.5%

FCF 3Y | 5Y -106.4% | -162.9%

Returns

ROA -66.6%

ROE -85.0%

ROIC -73.4%

Financial Health

Net Cash

$170.03M

Current Ratio 1.61

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic solutions that address critical unmet medical needs. The company currently offers two ...

Sector Healthcare

Industry Biotechnology

Employees 533

IPO Date Apr 11, 2006

Website www.vandapharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$21

Upside

+306.98%

Buy (3)

Hold (1)

Sell (0)

Analyst Details ➞